Autolus Therapeutics PLC reports results for the quarter ended in March - Earnings Summary

Autolus Therapeutics

04/05/2023 14:34

* Autolus Therapeutics PLC  AUTL.OQ  reported a quarterly
adjusted
loss of 23 cents​​ per share for the quarter ended in March. The
mean expectation of eight analysts for the quarter was for a
loss of 27 cents per share.
    * Revenue rose 678.3% to $1.29 million from a year ago;
analysts
expected $353.13 thousand. 
    * Autolus Therapeutics PLC's reported EPS for the quarter
was a
loss of 23 cents​.
    * The mean earnings estimate of analysts had risen by
about 26% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Autolus Therapeutics PLC shares had risen by 6.5% this
quarter and gained 3.2% so far this year.
    * The company reported a quarterly loss of $34.17 million.
    * Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.27          -0.23          Beat
 Dec. 31 2022      -0.27          -0.23          Beat
 Sep. 30 2022      -0.46          -0.47          Missed
 Jun. 30 2022      -0.42          -0.46          Missed